|
Hematologic Malignancies Grand Rounds - FY19 Recent Advances in the Management of Acute Myeloid Leukemia |
04/12/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 The Promises of CAR T Therapy in Multiple Myeloma |
04/19/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 RT in Relapsed Refractory DLBCL When to Call in the Marines |
04/26/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 |
05/03/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 |
05/10/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 A Mysterious Rash |
05/17/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 The Case For or Against Vyxoes in AML MRC at Duke |
05/24/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 |
05/31/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 Venetoclax and CLL: new indications, special patient populations, and open discussion of the Duke approach to toxicity mitigation |
06/07/2019 - 9:15am to 10:15am EDT |
|
Hematologic Malignancies Grand Rounds - FY19 Case Studies |
06/14/2019 - 9:15am to 10:15am EDT |
